High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression.
Yasinska IM, Gonçalves Silva I, Sakhnevych SS, Ruegg L, Hussain R, Siligardi G, Fiedler W, Wellbrock J, Bardelli M, Varani L, Raap U, Berger S, Gibbs BF, Fasler-Kan E, Sumbayev VV.
Yasinska IM, et al.
Oncoimmunology. 2018 Feb 27;7(6):e1438109. doi: 10.1080/2162402X.2018.1438109. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29872582
Free PMC article.